OpenAlex
PricingAboutJobs
Log inGet started
Work

Prevalence and Predictive Value of Intermittent Viremia With Combination HIV Therapy

HTML

Year: 2001
Type: article
Source: JAMA
DOI: 10.1001/jama.286.2.171
Authors: Diane V. Havlir, R Bassett, D Levitan, P Gilbert, P Tebas, A C Collier, M S Hirsch, C Ignacio, J Condra, H F Günthard, D D Richman, J K Wong
Institution: University of California San Diego
Language: English

Topic: HIV Research and Treatment
Subfield: Virology
Field: Immunology and Microbiology
Domain: Life Sciences
SDG: Good health and well-being

Open Access status: closed

Funders: National Science Foundation, U.S. Department of Veterans Affairs, Bristol-Myers Squibb, Eli Lilly and Company, Pfizer, GlaxoSmithKline, Gilead Sciences, Harvard University, University of Washington, ACT Government, Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung, Universität Zürich, National Institutes of Health, Center for AIDS Research, University of Washington, University of California, San Diego, National Institute of Allergy and Infectious Diseases
Awards: IN VIVO HIV LATENCY REVEALED BY POTENT ANTIVIRAL THERAPY, G2949335559, STATISTICAL AND DATA MANAGEMENT CENTER, ADULT ACTG CENTRAL GROUP, SAN DIEGO AIDS CLINICAL TRIAL UNIT, G9000304622, San Diego Center for AIDS Research (SD CFAR)
OpenAlex ID: W2120752160
FWCI: 9.812
Cites: 39
Cited by: 362
Related to: 10
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Supporters
Legal
Privacy
Accessibility
Terms